Completed PHASE2 INTERVENTIONAL 1-arm
NCT00148694
Preoperative Cisplatin in Early Stage Breast Cancer
A Phase II Trial of Cisplatin in Early Stage ER-, PR-, HER-2 Negative Breast Cancer
Sponsor: Beth Israel Deaconess Medical Center
Conditions
Breast Cancer
Interventions
Cisplatin
Updated 1 time since 2024 Last updated: Aug 29, 2016 Started: Jul 31, 2004 Primary completion: May 31, 2006 Completion: May 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00148694, this PHASE2 trial focuses on Breast Cancer and remains completed. Sponsored by Beth Israel Deaconess Medical Center, it has been updated 1 time since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Completed — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Beth Israel Deaconess Medical Center
- Breast Cancer Research Foundation
- Brigham and Women's Hospital
- Dana-Farber Cancer Institute
- Massachusetts General Hospital
Data source: Dana-Farber Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .